/

Tenvie

Developing brain-penetrant small molecule therapies for neurological diseases.

BiotechnologyPharmaceuticals tenvie.com ↗

Company facts

Founded: 2024
Employees: 50
Headquarters: United States
Type: Private
Funding: Series A · $200M · 2024